Oral vaccination with attenuated Salmonella enterica serovar Typhimurium expressing Cap protein of PCV2 and its immunogenicity in mouse and swine models

Veterinary Microbiology

Volumn 157, Issue 3-4, 2012, Pages 294-303

  Xu, Xin Gang ^a   Zhao, Hong Ni ^a   Zhang, Qi ^a   Ding, Li ^a   Li, Zhao Cai ^a   Li, Wei ^a   Wu, Hung Yi ^c   Chuang, Kuo Pin ^c   Tong, De Wen ^a   Liu, Hung Jen ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Attenuated S. typhimurium; Capsid protein; Porcine circovirus type 2; Vaccination

Indexed keywords

UNCLASSIFIED DRUG; VIRUS VACCINE; X4550 PYA3341 CAP PROTEIN;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BIOTRANSFORMATION; BLOOD SAMPLING; CD4 CD8 RATIO; CIRCOVIRUS; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; FLOW CYTOMETRY; GENE AMPLIFICATION; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOGENICITY; INOCULATION; LYMPHOCYTE PROLIFERATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PORCINE CIRCOVIRUS TYPE 2; RECOMBINANT PLASMID; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; SPLEEN; SWINE; SWINE DISEASE; VACCINATION; VIREMIA; VIRUS ATTENUATION; VIRUS INFECTION; VIRUS NEUTRALIZATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CAPSID PROTEINS; CD4-CD8 RATIO; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; FEMALE; IMMUNITY, CELLULAR; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PLASMIDS; SALMONELLA TYPHIMURIUM; SWINE; SWINE DISEASES; T-LYMPHOCYTE SUBSETS; VACCINATION; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL VACCINES;

BACTERIA (MICROORGANISMS); MIRIDAE; MUS; PORCINE CIRCOVIRUS 2; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SUIDAE;

EID: 84862797750     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.01.008     Document Type: Article

References (24)

1. Allan G.M., Ellis J.A. Porcine circoviruses: a review. J. Vet. Diagn. Invest. 2000, 12(1):3-14.
2. Bai Y., Zhang Y.L., Wang J.D., Zhang Z.S., Zhou D.Y. Construction of attenuated Salmonella typhimurium strain expressing Helicobacter pylori conservative region of adhesion antigen and its immunogenicity. World J. Gastroenterol. 2004, 10(17):2498-2502.
3. Chang H.W., Jeng C.R., Lin T.L., Liu J.J., Chiou M.T., Tsai Y.C., Chia M.Y., Jan T.R., Pang V.F. Immunopathological effects of porcine circovirus type 2 (PCV2) on swine alveolar macrophages by in vitro inoculation. Vet. Immunol. Immunopathol. 2006, 110(3-4):207-219.
4. Chen T., Cui Y., Bai C., Gong T., Peng X., Cui H. Decreased percentages of the peripheral blood T-cell subsets and the serum IL-2 contents in chickens fed on diets excess in fluorine. Biol. Trace Elem. Res. 2009, 132(1-3):122-128.
5. Cheung A.K., Bolin S.R. Kinetics of porcine circovirus type 2 replication. Arch. Virol. 2002, 147(1):43-58.
6. Ding J.T., Chen X.Y., Luo X.N., Wang Y., Zhang S.H., Liu B., Zheng Y.D., Jing Z.Z., Cai X.P. Construction of the recombinant live vector vaccine strain expressing taenia solium oncosphere 18 antigen. Sci. Agric. Sin. 2008, 41(12):4230-4237.
7. Fang W., Liang X., Jiang L. Safety, stability and immunogenecity of an oral DNA vaccine against Newcastle diseases. Chin. J. Biotechnol. 2003, 19(1):24-29.
8. Fan H., Pan Y., Fang L., Wang D., Wang S., Jiang Y., Chen H., Xiao S. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice. J. Virol. Methods 2008, 150(1-2):21-26.
9. Gahan M.E., Webster D.E., Wesselingh S.L., Wesselingh S.L., Strugnell R.A. Impact of plasmid stability on oral DNA delivery by Salmonella enterica serovar Typhimurium. Vaccine 2007, 25:1476-1483.
10. Horlen K.P., Dritz S.S., Nietfeld J.C., Henry S.C., Hesse R.A., Oberst R. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. J. Am. Vet. Med. Assoc. 2008, 232(6):906-912.
11. Karpenko L.I., Nekrasova N.A., Ilyichev A.A., Lebedev L.R., Ignatyev G.M., Agafonov P.A., Zaitsev B.N., Belavin P.A., Seregin S.V., Danilyuk N.K., Babkina I.N., Bazhan S.I. Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogen. Vaccine 2004, 22(13-14):1692-1699.
12. Kotton C.N., Hohmann E.L. Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect. Immun. 2004, 72(10):5535-5547.
13. Li J., Liang X., Huang Y., Meng S., Xie R., Deng R. Enhancement of the immunogenicity of DNA vaccine against infectious bursal disease virus by co-delivery with plasmid encoding chicken interleukin 2. Virology 2004, 329(1):89-100.
14. Pan Q.X., He K.W., Huang K.H. Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2. Vaccine 2008, 26(17):2119-2126.
15. Pasetti M.F., Levine M.M., Sztein M.B. Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors. Vaccine 2003, 21(5-6):401-418.
16. Pogranichnyy R.M., Yoon K.J., Harms P.A., Swenson S.L., Zimmerman J.J., Sorden S.D. Characterization of immune response of young pigs to porcine circovirus type 2 infection. Viral. Immunol. 2000, 13(2):143-153.
17. + effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 2002, 169(4):2196-2203.
18. + T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain CVD 908-htrA. J. Immunol. 2003, 170(5):2734-2741.
19. Sirard J.C., Niedergang F., Kraehenbuhl J.P. Live attenuated Salmonella: a paradigm of mucosal vaccines. Immunol. Rev. 1999, 171:5-26.
20. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory, New York. second ed.
21. Wang X., Jiang W., Jiang P., Li Y., Feng Z., Xu J. Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice. Vaccine 2006, 24(16):374-380.
22. Xing F.S., Xu X.G., Tong D.W., Wang Z.S., Liu W.J., Nin P.B., Zhang Y.M. Cloning, sequence analysis and prokaryotic expression of ORF2 gene of PCV2 Shaanxi strain. J. Northwest A&F Univ. (Nat. Sci. Ed.) 2010, 38(3):1-6.
23. Xu X.G., Wang Z.S., Zhang Q., Li Z.C., Ding L., Li W., Wu H.Y., Chang C.D., Lee L.H., Tong D.W., Liu H.J. Baculovirus as a PRRSV and PCV2 bivalent vaccine vector: baculovirus virions displaying simultaneously GP5 glycoprotein of PRRSV and capsid protein of PCV2. J. Virol. Methods 2012, 179:359-366.
24. Zhang Y.X., Li J.Q., Wang T.G. Isolation and identification of Salmonella typhimurium and Salmonella enteritidis. Chin. J. Vet. Sci. Technol. 1998, 28(9):26-37.